Quality and Outcomes of Treatment of Hypercalcemia of Malignancy

REFERENCES

• Stewart AF. Clinical practice. Hypercalcemia associated with cancer. N Engl J Med 2005;352:373–379.
   PubMed Web of Science ®Google Scholar
• Lumachi F, Brunello A, Roma A, Basso U. Cancer-induced hypercalcemia. Anticancer Res 2009;29:1551–1555.
   PubMed Web of Science ®Google Scholar
• Lewis MA, Hendrickson AW, Moynihan TJ. Oncologic emergencies: pathophysiology, presentation, diagnosis, and treatment. CA Cancer J Clin 2011; 61(5):287–314.
   PubMed Web of Science ®Google Scholar
• Vassilopoulou-Sellin R, Newman BM, Taylor SH, Guinee VF. Incidence of hypercalcemia in patients with malignancy referred to a comprehensive cancer center. Cancer 1993;71:1309–1312.
   PubMed Web of Science ®Google Scholar
• Ralston SH, Gallacher SJ, Patel U, Campbell J, Boyle IT. Cancer-associated hypercalcemia: morbidity and mortality. Clinical experience in 126 treated patients. Ann Intern Med 1990;112:499–504.
   PubMed Web of Science ®Google Scholar
• Major P, Lortholary A, Hon J, Abdi E, Mills G, Menssen HD, Yunus F, Bell R, Body J, Quebe-Fehling E, Seaman J. Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: a pooled analysis of two randomized, controlled clinical trials. J Clin Oncol 2001;19:558–567.
   PubMed Web of Science ®Google Scholar
• Gucalp R, Ritch P, Wiernik PH, Sarma PR, Keller A, Richman SP, Tauer K, Neidhart J, Mallette LE, Siegel R. Comparative study of pamidronate disodium and etidronate disodium in the treatment of cancer-related hypercalcemia. J Clin Oncol 1992;10: 134–142.
   PubMed Web of Science ®Google Scholar
• Castellano D, Sepulveda JM, Garcia-Escobar I, Rodriguez-Antolin A, Sundlov A, Cortes-Funes H. The role of RANK-ligand inhibition in cancer: the story of denosumab. Oncologist 2011;16:136–145.
   PubMed Web of Science ®Google Scholar
• Lindenauer PK, Pekow PS, Lahti MC, Lee Y, Benjamin EM, Rothberg MB. Association of corticosteroid dose and route of administration with risk of treatment failure in acute exacerbation of chronic obstructive pulmonary disease. JAMA 2010;303:2359–2367.
   PubMed Web of Science ®Google Scholar
• Rothberg MB, Pekow PS, Lahti M, Brody O, Skiest DJ, Lindenauer PK. Antibiotic therapy and treatment failure in patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease. JAMA 2010;303:2035–2042.
   PubMed Web of Science ®Google Scholar
• Lindenauer PK, Pekow P, Wang K, Mamidi DK, Gutierrez B, Benjamin EM. Perioperative beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med 2005;353:349–361.
   PubMed Web of Science ®Google Scholar
• Logan AC, Yank V, Stafford RS. Off-label use of recombinant factor VIIa in U.S. hospitals: analysis of hospital records. Ann Intern Med 2011;154:516–522.
   PubMed Web of Science ®Google Scholar
• Wright JD, Neugut AI, Ananth CV, Lewin SN, Wilde ET, Lu YS, Herzog TJ, Hershman DL. Deviations from guideline-based therapy for febrile neutropenia in cancer patients and their effect on outcomes. JAMA Internal Med 2013;173:559–568.
   PubMed Web of Science ®Google Scholar
• Wright JD, Ananth CV, Lewin SN, Burke WM, Lu YS, Neugut AI, Herzog TJ, Hershman DL. Robotically assisted vs laparoscopic hysterectomy among women with benign gynecologic disease. JAMA 2013;309:689–698.
   PubMed Web of Science ®Google Scholar
• Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373–383.
   PubMedGoogle Scholar
• Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613–619.
   PubMed Web of Science ®Google Scholar
• Wright JD, Burke WM, Wilde ET, Lewin SN, Charles AS, Kim JH, Goldman N, Neugut AI, Herzog TJ, Hershman DL. Comparative effectiveness of robotic versus laparoscopic hysterectomy for endometrial cancer. J Clin Oncol 2012;30:783–791.
   PubMed Web of Science ®Google Scholar
• Wright JD, Lewin SN, Deutsch I, Burke WM, Sun X, Herzog TJ. The influence of surgical volume on morbidity and mortality of radical hysterectomy for cervical cancer. Am J Obstet Gynecol 2011;205:225e1–225e7.
   Web of Science ®Google Scholar
• Hemmila MR, Birkmeyer NJ, Arbabi S, Osborne NH, Wahl WL, Dimick JB. Introduction to propensity scores: a case study on the comparative effectiveness of laparoscopic vs open appendectomy. Arch Surg 2010;145:939–945.
   PubMed Web of Science ®Google Scholar
• D'Agostino RB, Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 1998;17:2265–2281.
   PubMed Web of Science ®Google Scholar
• Stukel TA, Fisher ES, Wennberg DE, Alter DA, Gottlieb DJ, Vermeulen MJ. Analysis of observational studies in the presence of treatment selection bias: effects of invasive cardiac management on AMI survival using propensity score and instrumental variable methods. JAMA 2007;297:278–285.
   PubMed Web of Science ®Google Scholar
• Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res 2011;46:399–424.
   PubMed Web of Science ®Google Scholar
• Zoledronic Acid for Injection (Zometa). FDA Package Insert., 2001. (Accessed May 23, 2014, at http://www.accessdata.fda. gov/drugsatfda_docs/label/2001/21223lbl.pdf.)
   Google Scholar
• Pamidronate Disodium. FDA Package Insert., 2009. (Accessed May 23, 2014, at http://www.accessdata.fda.gov/drugsatfda_docs/ label/2009/021113s008lbl.pdf.)
   Google Scholar
• Berenson JR, Rosen L, Vescio R, Lau HS, Woo M, Sioufi A, Kowalski MO, Knight RD, Seaman JJ. Pharmacokinetics of pamidronate disodium in patients with cancer with normal or impaired renal function. J Clin Pharmacol 1997;37:285–290.
   PubMed Web of Science ®Google Scholar
• Machado CE, Flombaum CD. Safety of pamidronate in patients with renal failure and hypercalcemia. Clin Nephrol 1996;45:175–179.
   PubMed Web of Science ®Google Scholar
• Hershman DL, Wright JD, Lim E, Buono DL, Tsai WY, Neugut AI. Contraindicated use of bevacizumab and toxicity in elderly patients with cancer. J Clin Oncol 2013;31:3592–3599.
   PubMed Web of Science ®Google Scholar
• Tsai TT, Maddox TM, Roe MT, Dai D, Alexander KP, Ho PM, Messenger JC, Nallamothu BK, Peterson ED, Rumsfeld JS; National Cardiovascular Data Registry. Contraindicated medication use in dialysis patients undergoing percutaneous coronary intervention. JAMA 2009;302:2458–2464.
   PubMed Web of Science ®Google Scholar
• Lerose R, Musto P, Aieta M, Papa C, Tartarone A. Off-label use of anti-cancer drugs between clinical practice and research: the Italian experience. Eur J Clin Pharmacol 2012;68:505–512.
   PubMed Web of Science ®Google Scholar
• Hershman DL, Wilde ET, Wright JD, Buono DL, Kalinsky K, Malin JL, Neugut AI. Uptake and economic impact of first-cycle colony-stimulating factor use during adjuvant treatment of breast cancer. J Clin Oncol 2012;30:806–812.
   PubMed Web of Science ®Google Scholar
• Werner RM, Bradlow ET. Relationship between Medicare's hospital compare performance measures and mortality rates. JAMA 2006;296:2694–2702.
   PubMed Web of Science ®Google Scholar
• Werner RM, Bradlow ET, Asch DA. Hospital performance measures and quality of care. LDI Issue Brief 2008;13:1–4.
   PubMedGoogle Scholar
• Werner RM, Bradlow ET. Public reporting on hospital process improvements is linked to better patient outcomes. Health Aff (Millwood) 2010;29:1319–1324.
   PubMed Web of Science ®Google Scholar
• Werner RM, Bradlow ET, Asch DA. Does hospital performance on process measures directly measure high quality care or is it a marker of unmeasured care? Health Serv Res 2008;43: 1464–1484.
   PubMed Web of Science ®Google Scholar
• Stulberg JJ, Delaney CP, Neuhauser DV, Aron DC, Fu P, Koroukian SM. Adherence to surgical care improvement project measures and the association with postoperative infections. JAMA 2010;303:2479–2485.
   PubMed Web of Science ®Google Scholar
• Lindenauer PK, Rothberg MB, Pekow PS, Kenwood C, Benjamin EM, Auerbach AD. Outcomes of care by hospitalists, general internists, and family physicians. N Engl J Med 2007;357: 2589–3600.
   PubMed Web of Science ®Google Scholar